Quantifying the potential benefit of CA 125 screening for ovarian cancer-Reference-Cited by-同舟云学术

Quantifying the potential benefit of CA 125 screening for ovarian cancer

Published:1991-01 Issue:4-5 Volume:44 Page:365-380
ISSN:0895-4356
Container-title:Journal of Clinical Epidemiology
language:en
Short-container-title:Journal of Clinical Epidemiology

Author:

Skates Steven J.,Singer Daniel E.

Publisher

Elsevier BV

Subject

Epidemiology

Reference41 articles.

1. Cancer statistics 1981;Silverberg;Cancer,1981

2. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer;Bast;N Engl J Med,1983

3. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas;Klug;Cancer Res,1984

4. Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma;Bast;Gynecol Oncol,1984

5. Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer;Zurawski;Int J Cancer,1988

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical performance and utility: A microsimulation model to inform the design of screening trials for a multi-cancer early detection test;Journal of Medical Screening;2024-02-02

2. Liquid biopsy in ovarian cancer in China and the world: current status and future perspectives;Frontiers in Oncology;2023-12-19

3. Identification of SAA1 as a novel metastasis marker in ovarian cancer and development of a graphene-based detection platform for early assessment;Journal of Cancer Research and Clinical Oncology;2023-09-14

4. Biomarkers in ovarian cancer and saliva: An update;Journal of Reproductive Healthcare and Medicine;2021-01-16

5. Modeled Reductions in Late-stage Cancer with a Multi-Cancer Early Detection Test;Cancer Epidemiology Biomarkers & Prevention;2020-12-16